Systemic Chemotherapy Based on Oxaliplatin and 5-fluorouracil, Apatinib Plus Sintilimab for Metastasis ICC: a Single Arm Prospective Study
Latest Information Update: 05 Feb 2021
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Rivoceranib (Primary) ; Sintilimab (Primary)
- Indications Cholangiocarcinoma
- Focus Therapeutic Use
- 01 Feb 2021 Planned End Date changed from 1 Dec 2021 to 1 Feb 2021.
- 01 Feb 2021 Planned primary completion date changed from 1 Jul 2021 to 1 Feb 2021.
- 01 Feb 2021 Status has been changed to withdrawn prior to enrolment.